Microbiologics, a global biotechnology leader specializing in infectious disease reference materials and contract research services, is excited to announce the acquisition of SensID, a leading manufacturer of reference materials and quality controls for molecular diagnostics with a focus on oncology and precision medicine. Founded in 2015, SensID is based in Rostock, Germany where they will continue operations post-acquisition, marking Microbiologics’ first location outside the United States. This acquisition marks a significant milestone in Microbiologics’ mission of advancing a safer, healthier world by expanding its reach into the field of oncology and precision medicine, while continuing its leadership in infectious disease diagnostics.
Read the full article: Microbiologics Acquires SensID, Expanding Expertise in Diagnostic Quality Controls //
Source: https://www.prnewswire.com/news-releases/microbiologics-acquires-sensid-expanding-expertise-in-diagnostic-quality-controls-302297067.html